$CLDX Income Statement | Understand Stock

$CLDX

$30.15 +$0.65 (2.2%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product development and licensing agreements
Contracts and grants
Total revenues
Operating expenses:
Research and development
General and administrative
Intangible asset impairment
Gain on fair value remeasurement of contingent consideration
Litigation settlement related loss
Total operating expenses

Operating loss
Investment and other income, net
Income tax benefit
Net loss
Net loss
Other comprehensive income (loss):
Unrealized gain on marketable securities
Comprehensive loss
Basic net loss per common share (in dollars per share)
Diluted net loss per common share (in dollars per share)
Shares used in calculating basic net loss per share (in shares)
Shares used in calculating diluted net loss per share (in shares)

Comments